Danaher (DHR) October 25 weekly call option implied volatility into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Tech stocks bolster Wall Street as Nvidia quells AI growth concerns
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil rises by over $1 as White House says no US-Iran talks happening
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Revolution Medicines prices RASONQUE at $39,800 per month
Danaher (DHR) PT Lowered to $277 at Baird
October 23, 2024 6:25 AM EDTBaird analyst Catherine Schulte lowered the price target on Danaher (NYSE: DHR) to $277.00 (from $278.00) while maintaining a Outperform rating.
The analyst comments "Maintain Outperform rating, new $277 price target (-$1). DHR reported 3Q results ahead of expectations, driven by Biotechnology and Cepheid respiratory upside.... More
Danaher (DHR) PT Lowered to $275 at Leerink Partners
October 23, 2024 6:05 AM EDTLeerink Partners analyst Puneet Souda lowered the price target on Danaher (NYSE: DHR) to $275.00 (from $280.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: We see DHR as the leader in the highly attractive, spec'd-in and recurring rev market of bioprocess tools,... More
